Coronavirus Update: Pfizer Vaccine Candidates Gain Fast-Track Status

Two mRNA Candidates Selected

The granting of fast-track status is a clear signal that the US FDA wants to maintain its high standards of drug and vaccine appraisal.

Face covering
Face coverings will be mandatory in England's shops from 24 July, bringing it into line with Scotland and other European nations such as Spain, Italy and Germany.

Two of the four investigational COVID-19 vaccine candidates being developed by Pfizer Inc. and BioNTech have gained fast track designation from the US Food and Drug Administration.

The two candidates using the mRNA-based vaccine platform are BNT162b1 and BNT162b2 and are the most advanced in the partners’...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip